Hematopoietic stem cell transplantation and implications for cell therapy reimbursement |
| |
| Authors: | Maziarz Richard T Driscoll Dawn |
| |
| Affiliation: | 1. Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA;2. Principal, DCi Biotech, Cell Therapy Commercialization, Perth 6000, Australia |
| |
| Abstract: | As costly stem cell treatments progress from experimental concepts toward licensed products and routine procedures, governmental and private payers grapple with shrinking budgets to cover more lives. We describe efforts underway in the US to create mechanisms for reimbursement of cell therapies and discuss other reimbursement-related issues for the stem cell community. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
